Noor Ul Ain Rehman
Tue, March 31, 2026 astatine 10:30 AM CDT 2 min read
Robert M. Davis, president and main enforcement officer, Merck & Co., Inc. (NYSE:MRK), stated that the acquisition of Terns builds connected the company’s increasing beingness successful hematology with TERN-701, which is simply a imaginable best-in-class campaigner to dainty definite patients with chronic myeloid leukemia. He added that the transaction diversifies and bolsters Merck & Co., Inc.’s (NYSE:MRK) presumption successful oncology, arsenic it continues to look for opportunities that tin assistance the institution broaden its portfolio into different therapeutic areas.
Merck & Co., Inc. (NYSE:MRK) is simply a biopharmaceutical institution that delivers wellness solutions to beforehand the attraction and prevention of diseases successful animals and people. Its Pharmaceutical conception offers vaccines and quality wellness pharmaceutical products, typically therapeutic and preventive agents. Its Animal Health conception develops, discovers, manufactures, and markets a scope of vaccines and veterinary pharmaceutical products. The company’s medicine KEYTRUDA whitethorn dainty definite cancers by moving with the immune system.
While we admit the imaginable of MRK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 hours ago
2





English (CA) ·
English (US) ·
Spanish (MX) ·